Advances in understanding the molecular pathogenesis of CTCL

2 Views
administrator
administrator
08/09/23

Rudolf Stadler, MD, PhD, University Medical Center Minden, Minden, Germany, discusses recent advances in our understanding of the molecular pathogenesis of cutaneous T-cell lymphoma (CTCL), highlighting the role of PD-1, and commenting on how these developments may advance therapeutic approaches. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next